Hematology - Hematology Xagena

Hematology

News

Drugs

Xagena Medicine

Xagena.net

Role of EBNA3CB in B-cell lymphoma and other EBV-associated illnesses

Sickle cell disease: Nitric oxide may help normalize hemoglobin

Menin in the development of some forms of acute leukemia

Patients surviving childhood Hodgkin disease suffer stroke later in life

ERG may play a key role in development of myeloid leukemia

Forskolin may be effective in Imatinib-resistant patients in chronic myelogenous leukaemia

Protective conditioning protects against GVHD in hematopoietic-cell transplantation

Ibritumomab tiuxetan associated with severe cutaneous or mucocutaneous reactions

Higher risk of death in the elderly with anemia

CD19 monoclonal antibody could treat leukemias, autoimmune diseases, transplant rejection

Heme controls antioxidants and iron in ferritin

Exjade: FDA Panel recommends approval for once-daily oral treatment of chronic iron overload due to blood transfusions

KLF2 protein is crucial for normal development and regulation of erythrocytes

Acute myeloid leukemia patients with 8;21 translocation: need for different therapy

Lenalidomide and Dexamethasone show promise in treatment of multiple myeloma

Anemia: new pathway for the synthesis of heme

Thalidomide in combination with Dexamethasone is better than conventional chemotherapy in multiple myeloma

Oral liquid Hydroxyurea prevents onset of long-term complications in sickle cell anemia

Bortezomib is superior to high-dose Dexamethasone in relapsed multiple myeloma

Relapsed or refractory follicular lymphoma: Galiximab and Rituximab may extend event-free survival

Gene therapy produces partial correction to bleeding problems in murine model of hemophilia

Experimental vaccine can prime the immune system against mantle cell lymphoma

BRIP1 mutations may have a role in development of Fanconi anemia

Potential role of Bortezomib as frontline therapy in multiple myeloma

Non-Hodgkin’s lymphoma: alcohol may reduce risk

Myelodysplastic syndromes: Lenalidomide in low and intermediate-1 risk

A combination with Bortezomib overcomes drug-resistant myeloma cells

Increased risk of leukemia for children close to power lines at birth

Asians and Pacific Islanders have the highest levels of iron

Hematopoietic stem cells: Notch a key regulator

Next Pages 1 [2] 3

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions